Financials

  • Market Capitalization 396.11 M
  • Employee 120
  • Founded 1995
  • CEO N/A
  • Website www.enanta.com
  • Headquarter Massachusetts, United States
  • FIGI BBG001V9NSB4
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.12
Relación precio/flujo de caja
0

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3076
XFOR
X4 Pharmaceuticals, Inc. - Common Stock
4.04 USD-4.49%+0.25%+2.02%+36.03%400.55 M USD
3079
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.86 USD-2.61%-0.41%+11.47%+1.89%398.74 M USD
3094
CTNM
Contineum Therapeutics, Inc. - Common stock
17.05 USD-1.16%+0.29%+17.75%+11.66%393.84 M USD
3108
EYPT
EyePoint, Inc. - Common Stock
4.48 USD-3.24%-13.35%-63.19%-62.67%386.23 M USD

Noticias